Tags: wall street | stock market | dow | s&p 500

S&P Hits Record High Close as Earnings Add to Vaccine Optimism

S&P Hits Record High Close as Earnings Add to Vaccine Optimism
(Louisscott/Dreamstime)

Friday, 13 November 2020 04:08 PM

The S&P 500 notched a record closing high on Friday with upbeat earnings reports helping to drive optimism about the economy along with hopes for successful COVID-19 vaccines, even as investors monitored a surge in virus cases and restrictions around the country.

After a volatile trading week where the market was whipsawed between hopes and fears around the virus, Cisco Systems provided the biggest boost to the S&P 500 after its quarterly report showed a work-from-home driven surge in demand.

Walt Disney also rose as its rapidly growing streaming video business, and a partial recovery at its theme parks tempered its quarterly loss.

"At least for today it looks like sentiment regarding the potential for vaccines combined with very strong earnings announcements from a number of companies has investors hopeful that the economy can continue to recover," said Michael Arone, chief investment strategist at State Street Global Advisors.

The Dow Jones Industrial Average rose 399.64 points, or 1.37%, to 29,479.81, the S&P 500 gained 48.14 points, or 1.36%, to 3,585.15 and the Nasdaq Composite added 119.70 points, or 1.02%, to 11,829.29.

Along with the S&P, the small cap Russell 2000 also registered a record closing high on Friday, rising 2.1% on the day.

Friday's outperformance of more economically sensitive cyclical sectors including energy, real estate and industrials over growth sectors like technology was a clear indication of "optimism around the economy" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta.

The Russell 1000 value index, which is heavily weighted toward cyclical sectors such as banks and energy, rose 1.97% on Friday while the growth index, with a large tech company weighting, added 0.7%.

The three major U.S. stock indexes had fallen on Thursday as more than a dozen U.S. states reported a doubling of new COVID-19 cases in the last two weeks, with Chicago's mayor issuing a month-long stay-at-home advisory.

President Donald Trump and Democrat Joe Biden have said there were no plans for nationwide lockdowns and instead talked about restrictions for specific regions when the virus spread is bad there.

State Street's Arone said the aversion to a full lockdown likely cheered up some investors but that optimism may be overdone. He cited Fed official warnings about the potential economic damage rising virus cases could do without a fresh economic stimulus package in sight.

"The market is underestimating some of the impact that rising cases and no stimulus will have on the economy and earnings and they're over estimating the potential timeline and breadth of a vaccine distribution," Arone said.

"In the spring folks were bracing for the worst and the worst didn't happen. Now they're expecting the best and they may be a little too rosy."

Positive data from Pfizer's virus vaccine study on Monday had prompted a rally that pushed the S&P 500 up 2.2% for the week and gave the Dow a 4% weekly gain. The indexes also registered their biggest two-week percentage gains since April.

The tech-heavy Nasdaq, however, showed a 0.6% decline for the week as investors booked profits in technology stocks, which have benefited from a stay-at-home environment.

Globalt's Martin also pointed to investor hopes for news of more coronavirus vaccine progress soon, after Moderna Inc said earlier this week that it had enough data for a first interim analysis of its late-stage trial.

With third-quarter reports released from about 90% of S&P 500 companies Refinitiv IBES estimates now show profits falling 7.8% from last year compared with an Oct. 1 expectation for a 21.4% slump.

Advancing issues outnumbered declining ones on the NYSE by a 4.76-to-1 ratio; on Nasdaq, a 2.83-to-1 ratio favored advancers.

The S&P 500 posted nine new 52-week highs and no new lows; the Nasdaq Composite recorded 84 new highs and 11 new lows.

On U.S. exchanges 9.86 billion shares changed hands compared with the 10.1 billion average for the last 20 sessions. 

GLOBAL STOCKS

European stocks ended flat as rising fears of economic damage from the pandemic offset recent vaccine optimism. Still, the benchmark index notched its second straight week of gains.

The pan-European STOXX 600 index rose 0.01% and MSCI's gauge of stocks across the globe gained 0.83%.

U.S. Treasury yields were mixed as investors consolidated positions ahead of the weekend and remained cautious given the surge in coronavirus cases. But the yield curve steepened on Friday, after flattening the previous session.

Benchmark 10-year notes last fell 2/32 in price to yield 0.893%, from 0.886% late on Thursday.

The 30-year bond last rose 6/32 in price to yield 1.6442%, from 1.652% late on Thursday.

U.S. crude dropped 2.41% to settle at $40.13 per barrel, while Brent settled at $42.78 per barrel, down 1.72% on the day.

The dollar was down, but safe-haven yen and Swiss franc currencies strengthened, reflecting a loss of risk appetite driven by vaccine hopes.

The dollar index fell 0.23%, with the euro up 0.23% to $1.1831.

The Japanese yen strengthened 0.48% versus the greenback at 104.64 per dollar, while Sterling was last trading at $1.3195, up 0.62% on the day.

Gold prices rose as rising global coronavirus infections sparked renewed fears over the pandemic's economic toll.

Spot gold added 0.6% to $1,887.78 an ounce.

© 2020 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
StreetTalk
The S&P 500 notched a record closing high on Friday with upbeat earnings reports helping to drive optimism about the economy along with hopes for successful COVID-19 vaccines, even as investors monitored a surge in virus cases and restrictions around the country.
wall street, stock market, dow, s&p 500
863
2020-08-13
Friday, 13 November 2020 04:08 PM
Newsmax Media, Inc.
 
Newsmax TV Live

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved